Pancreatic Cancer Research

ResearcherYonsei UniversityActive in the last 2 years

Dong Sup Yoon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-6444-9606; OpenAlex author ID A5079104635. Sources: ClinicalTrials.gov.

Their work

Papers
14 (first author 0, last author 5)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
50
Papers, trials and grants by year

2007: 1 trial · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: 3 papers · 2018: 1 paper · 2019: 2 papers · 2020: 2 papers · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 14

  1. Impaired insulin secretion via the Wnt5a/β-catenin pathway contributes to diabetes development in pancreatic cancer. Co-author DOI 10.1038/s12276-025-01625-8↗
  2. Radical antegrade modular pancreatosplenectomy (RAMPS) versus conventional distal pancreatectomy for left-sided pancreatic cancer: findings of a multicenter, r… Last author DOI 10.1007/s00595-021-02280-y↗
  3. Is Neoadjuvant Treatment Justified in Clinical T1 Pancreatic Ductal Adenocarcinoma? Last author DOI 10.3390/jcm10040873↗
  4. Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinoma. Co-author DOI 10.1111/jgh.14837↗
  5. A nomogram to preoperatively predict 1-year disease-specific survival in resected pancreatic cancer following neoadjuvant chemoradiation therapy. Co-author DOI 10.21147/j.issn.1000-9604.2020.01.12↗
  6. Specific protein 1(SP1) regulates the epithelial-mesenchymal transition via lysyl oxidase-like 2(LOXL2) in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41598-019-42501-6↗
  7. Association of preoperative total lymphocyte count with prognosis in resected left-sided pancreatic cancer. Co-author DOI 10.1111/ans.15030↗
  8. Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospect… Co-author DOI 10.1097/sla.0000000000002705↗
  9. Preoperative fecal elastase-1 is a useful prognostic marker following curative resection of pancreatic cancer. Last author DOI 10.1016/j.hpb.2016.12.007↗
  10. Surgical management of malignant bowel obstruction in recurrent pancreatic cancer. Last author DOI 10.1016/j.ijscr.2017.01.021↗
  11. ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer. Co-author DOI 10.1038/bjc.2017.355↗
  12. Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma. Co-author DOI 10.4143/crt.2015.400↗
  13. A Study on the Dietary Intake and the Nutritional Status among the Pancreatic Cancer Surgical Patients. Co-author DOI 10.7762/cnr.2016.5.4.279↗
  14. Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer. Co-author DOI 10.4143/crt.2013.158↗

Trials 1

  1. Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy Principal investigator NCT00809081↗

Closest collaborators

The 25 strongest of 50 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Joon Seong Park · 9 shared papers, 2016–2021 · strength 0.87
  2. Hyung Sun Kim · 4 shared papers, 2017–2021 · strength 0.52
  3. Ho Kyoung Hwang · 3 shared papers, 2019–2020 · strength 0.32
  4. Chang Moo Kang · 3 shared papers, 2019–2020 · strength 0.32
  5. Woo Jung Lee · 3 shared papers, 2019–2020 · strength 0.32
  6. Minyoung Lee · 1 shared paper, 2026 · strength 0.26
  7. Shinae Kang · 1 shared paper, 2026 · strength 0.26
  8. Jin Hong Lim · 2 shared papers, 2017 · strength 0.21
  9. Tae Ho Hong · 1 shared paper, 2021 · strength 0.17
  10. Kota Nakamura · 1 shared paper, 2021 · strength 0.14
  11. Kenji Nakagawa · 1 shared paper, 2021 · strength 0.14
  12. Masayuki Sho · 1 shared paper, 2021 · strength 0.14
  13. Tadataka Takagi · 1 shared paper, 2021 · strength 0.14
  14. Takahiro Akahori · 1 shared paper, 2021 · strength 0.14
  15. Dong Ki Lee · 2 shared papers, 2015–2016 · strength 0.12
  16. Min Goo Lee · 2 shared papers, 2016–2017 · strength 0.12
  17. Hei‐Cheul Jeung · 2 shared papers, 2016–2017 · strength 0.12
  18. Hyung Soon Park · 2 shared papers, 2016–2017 · strength 0.12
  19. Im-kyung Kim · 1 shared paper, 2019 · strength 0.11
  20. Jae Uk Chong · 1 shared paper, 2019 · strength 0.11
  21. Seoung Yoon Rho · 1 shared paper, 2019 · strength 0.11
  22. Yun Sun Lee · 1 shared paper, 2019 · strength 0.11
  23. Keita Wada · 1 shared paper, 2020 · strength 0.11
  24. Yuichi Nagakawa · 1 shared paper, 2020 · strength 0.11
  25. Seung Woo Park · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.